Globe Newswire

NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX: MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the third quarter ended March 31, 2024.

Mesoblast Chief Executive Silviu Itescu said: “We are very pleased with the positive interactions we had last quarter with the FDA, having received clarity on the path to licensure for our product candidates in pediatric acute... (continue reading...)

TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Entrepreneur, philanthropist, and author of 633 Days Inside, Greg Lindberg recently took center stage on the Mentors Collective Podcast, engaging in a comprehensive dialogue with host Dr. Jay Feldman. The 45-minute interview covered a spectrum of topics, ranging from business and leadership to overcoming adversity, achieving longevity, and prioritizing wellness. The interview has gone viral with over 50,000 views.

• 2023 Adjusted Revenue1 record revenue of $17.05 million, an increase of 102% compared to 2022.
• 2023 GAAP revenue was $11.51 million an increase of 170% compared to 2022.
• 2023 gross margin of 43.11% compared to 43.00% in 2022.
• Q4, 2023 Adjusted Revenue1 of $4.99 million, an increase of 77% compared to Q4, 2022.
• Q4, 2023 GAAP revenue was $3.37 million an increase of 99% compared to Q4, 2022.
• Q4, 2023 gross margin of 46.54% compared to 43.77% in Q4, 2022
• Expanded service... (continue reading...)

NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), Doximity, Inc. (NYSE: DOCS), Global Cord Blood Corporation (OTC: CORBF), and Lincoln National Corporation (NYSE: LNC). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.... (continue reading...)

TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended February 29, 2024 (“Q1 2024”) compared to the same period last year (“Q1 2023”). All financial figures are in... (continue reading...)